Intellipharmaceutics (IPCI) Reports Q3 Loss of $0.08/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. GILD
9. SBUX
10. SNDK

Go back to Intellipharmaceutics (IPCI) Reports Q3 Loss of $0.08/Share

Intellipharmaceutics Announces Third Quarter 2017 Results

October 10, 2017 5:20 PM EDT

TORONTO, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (NASDAQ: IPCI) (TSX: IPCI) (Intellipharmaceutics or the Company), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today reported the results of operations for the three and nine months ended August 31, 2017.  All dollar amounts referenced herein are in United States dollars unless otherwise noted. 

Third Quarter Highlights

Revenues increase to $1.2 million from $0.6 million in third quarter 2016Mallinckrodt LLC (Mallinckrodt) launched all... More